Sign in
Home
Biz News
New Products
Cell Therapy
Medical Devices
Journal Papers
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, March 23, 2023
Sign in / Join
Contact
About
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Cell Tribune: Cell and Gene Therapy News and Research
Home
Biz News
U.S. Food and Drug Administration Places Clinical Hold On Cellectis MELANI-01 Study
New Antimicrobial Resistance (AMR) Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
New Products
CAR-T cell therapy benefits limited to few patients because of ‘Insurance Snags’
Helix BioPharma Corp. announces the signing of a non-binding letter of intent with ProMab Biotechnologies to develop cell based therapies
Cell Therapy
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases
Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients
Sigilon Therapeutics approaches the clinic
MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing
ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meeting
Medical Devices
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Intarcia Therapeutics Secures Additional $206M Financing; Gates Foundation to Invest up to $140M in Grants and Equity
Bionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
Journal Papers
Immunotherapy gel targets lingering tumor cells after surgery
‘Decorated’ Stem Cells Could Offer Targeted Heart Repair
Stem cell biologist at Harvard retracts diabetes breakthrough manuscript published in Cell citing reproducibility issues
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche
Business
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Cell Tribune
-
October 14, 2019
0
Business
GSK and Lyell Immunopharma join forces to develop the next generation...
Cell Tribune
-
October 9, 2019
0
Cell Therapy
ViaCyte Presented Preliminary PEC-Direct Clinical Data at Cell & Gene Meeting...
Cell Tribune
-
October 5, 2019
0
Cell Therapy
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start...
Cell Tribune
-
January 21, 2019
0
Immunotherapy
Immunotherapy gel targets lingering tumor cells after surgery
Cell Tribune
-
January 1, 2019
0
Business
Wuxi AppTec to expand facilities and operations to support cell and...
Cell Tribune
-
January 1, 2019
0
Cell Therapy
Positive 12-Month Data on BioCardia’s Investigational CardiAMP Cell Therapy System for...
Cell Tribune
-
November 13, 2018
0
Business
Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion...
Cell Tribune
-
October 15, 2018
0
Business
SQZ Biotech And Roche Expand Cell Therapy Partnership
Cell Tribune
-
October 15, 2018
0
Cell Therapy
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Cell Tribune
-
September 17, 2018
0
1
2
3
...
8
Page 2 of 8
62
Followers
Follow
EDITOR PICKS
Cancer immune therapy developed from ‘miraculous’ recovery patients
Cell Tribune
-
November 24, 2017
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T...
Cell Tribune
-
February 7, 2020
FDA Grants Breakthrough Therapy Designation to Novartis’s CAR-T Cell Therapy CTL019
Cell Tribune
-
April 22, 2017
ViaCyte Announces First Patients Implanted with PEC-Direct Islet Cell Replacement Therapy in International Clinical...
Cell Tribune
-
August 1, 2017
